Bloomberg Anywhere Remote Login Bloomberg Terminal Demo Request


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

November 25, 2015 9:57 AM ET


Company Overview of OncoMed Pharmaceuticals, Inc.

Executive Profile

Larry Norton M.D.

Member of Scientific & Clinical Advisory Board, OncoMed Pharmaceuticals, Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 2 different industries.

See Board Relationships


Dr. Larry Norton, M.D., serves as the Medical Director of MSK-64the Street. Dr. Norton also serves as a Deputy Physician-in-Chief for Breast Cancer Programs at Memorial Sloan-Kettering Cancer Center (MSKCC). Dr. Norton is the Deputy Physician-in-Chief at Memorial Hospital. He has the responsibility for breast cancer programs. He serves as the President of the National Alliance of Breast Cancer Organizations (NABCO). He is Professor of Medicine at Weill Medical College ...

Corporate Headquarters

800 Chesapeake Drive
Redwood City, California 94063

United States

Phone: 650-995-8200
Fax: 650-995-8600

Board Members Memberships

Ex-Officio Director


Columbia University
Unknown/Other Education
Albert Einstein College of Medicine

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact OncoMed Pharmaceuticals, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at